Avalyn Pharma Inc. Company Profile
Avalyn Pharma Inc. as SEC EDGAR records it: incorporation, addresses, industry, fiscal year end, filer category and former names.
- Current registered country: Value Delaware, United States.
- Country of operation (business address): Value United States.
- Business address: Value 105 W FIRST ST., BOSTON, Massachusetts, 02127, United States.
- Mailing address: Value 105 W FIRST ST., BOSTON, Massachusetts, 02127, United States.
| Measure | Value |
|---|---|
| Current registered country | Delaware, United States SEC EDGAR state of incorporation DE |
| Country of operation (business address) | United States |
| Business address | 105 W FIRST ST., BOSTON, Massachusetts, 02127, United States |
| Mailing address | 105 W FIRST ST., BOSTON, Massachusetts, 02127, United States |
| Industry (SIC) | 2834 Pharmaceutical Preparations |
| Fiscal year end | 12-31 |
| Filer category | <br>Emerging growth company |
| Listed stock (Section 12(b)) | Voting Common Stock, $0.001 par value per share · AVLN · Nasdaq Global Select Market 10-Q filed 2026-08-12 cover |
| Shell company | No 10-Q filed 2026-08-12 cover |
| Smaller reporting company | Yes 10-Q filed 2026-08-12 cover |
| Emerging growth company | Yes 10-Q filed 2026-08-12 cover |
| Current in its reporting | No 10-Q filed 2026-08-12 cover |
| Former names | Genoa Pharmaceuticals, Inc. (2012-11-16 to 2017-05-24) |
| First EDGAR filing | 2012-11-16 (D) |
| SEC CIK | 1540171 |
| EIN | 452463191 |
| Phone | (206) 707-0340 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B |